Health Care
Commentary
Debate: Is the Affordable Care Act Bad for America? with Sally Pipes
UVA Miller Center 2014 National Debate Series: Beyond Gridlock Affordable Care Act: Why Are So Many People Against It? Moderator Douglas Blackmon, Pulitzer Prize-winning author and journalist Panelists: Jonathan Cohn, Senior Editor, The New Republic Sally C. Pipes, CEO & President, Pacific Research Institute Avik Roy, Senior Fellow Healthcare, Manhattan ...
California
California greases skids for Obamacare
Gov. Arnold Schwarzenegger has signed two bills that he touts as reforms to “provide affordable and quality health care insurance.” In reality, Senate Bill 900 and Assembly Bill 1602 create a new bureaucracy — outside the normal controls of even the governor and state Legislature — to dictate which insurance ...
Business & Economics
Golden State offers tarnished ideas
Huge deficits and mounting debt. Increasing concern about creditworthiness. Large and growing government. Constant calls for higher taxes. High unemployment and a discouraged, even fearful, business community. Welcome to California. If you thought we were describing Washington, you had good reason. In instance after instance, Washington has mimicked the failed ...
Commentary
Dangers of mandating medical loss ratios
John R. Graham of the Pacific Research Institute discusses the harms of the medical loss ratios mandated in ObamaCare (HR 3590): One of the ways in which ObamaCare will reduce individuals’ and businesses’ choices of health insurance is through regulating the Medical Loss Ratio (MLR), a relatively simple concept: Take ...
Commentary
Avastin: Helpful drug or too risky, expensive?
In an “Urgent Submission on Breast Cancer” to newspaper editors, Sally C. Pipes (president and CEO of the Pacific Research Institute and author of “The Truth About Obamacare”) outlined only the positive parts of the Avastin story and implied that saving money was the real reason for this recommendation. She ...
Commentary
Americans’ healthy dislike for Obamacare
Supporters of President Barack Obama’s health care overhaul maintained throughout the summer that the law was slowly, but surely, growing in popularity. “The more people understand this bill, the more they are going to like it,” Secretary of Health and Human Services Kathleen Sebelius recently said. Public opinion data tell ...
Commentary
The Era of Rationing Begins
Supporters of health reform said it would never happen. Maybe they got caught up in their own rhetoric. Maybe they just didn’t want to believe it was possible. But rationing in America has started. By December, the Food and Drug Administration is expected to revoke approval of the drug Avastin ...
Commentary
Federal Pre-Emption Has a Place, but Maybe Not This One
Jay Lefkowitz and Michael Shumsky (“Obama Embraces the ‘Pre-Emption’ Doctrine,” op-ed, Sept. 14) make some valid arguments applicable to legal trade-offs between states’ product-liability laws and the Food and Drug Administration’s labeling regulations. However, they are off-base in describing the FDA as “cash-strapped.” The FDA’s spending on the regulation of ...
Health Care
GOP Pledge on Health Care: “Repeal” is Great; “Replace” Needs Work
Read my entire response at National Review Online .
Debate: Is the Affordable Care Act Bad for America? with Sally Pipes
UVA Miller Center 2014 National Debate Series: Beyond Gridlock Affordable Care Act: Why Are So Many People Against It? Moderator Douglas Blackmon, Pulitzer Prize-winning author and journalist Panelists: Jonathan Cohn, Senior Editor, The New Republic Sally C. Pipes, CEO & President, Pacific Research Institute Avik Roy, Senior Fellow Healthcare, Manhattan ...
California greases skids for Obamacare
Gov. Arnold Schwarzenegger has signed two bills that he touts as reforms to “provide affordable and quality health care insurance.” In reality, Senate Bill 900 and Assembly Bill 1602 create a new bureaucracy — outside the normal controls of even the governor and state Legislature — to dictate which insurance ...
Golden State offers tarnished ideas
Huge deficits and mounting debt. Increasing concern about creditworthiness. Large and growing government. Constant calls for higher taxes. High unemployment and a discouraged, even fearful, business community. Welcome to California. If you thought we were describing Washington, you had good reason. In instance after instance, Washington has mimicked the failed ...
Dangers of mandating medical loss ratios
John R. Graham of the Pacific Research Institute discusses the harms of the medical loss ratios mandated in ObamaCare (HR 3590): One of the ways in which ObamaCare will reduce individuals’ and businesses’ choices of health insurance is through regulating the Medical Loss Ratio (MLR), a relatively simple concept: Take ...
Avastin: Helpful drug or too risky, expensive?
In an “Urgent Submission on Breast Cancer” to newspaper editors, Sally C. Pipes (president and CEO of the Pacific Research Institute and author of “The Truth About Obamacare”) outlined only the positive parts of the Avastin story and implied that saving money was the real reason for this recommendation. She ...
Americans’ healthy dislike for Obamacare
Supporters of President Barack Obama’s health care overhaul maintained throughout the summer that the law was slowly, but surely, growing in popularity. “The more people understand this bill, the more they are going to like it,” Secretary of Health and Human Services Kathleen Sebelius recently said. Public opinion data tell ...
The Era of Rationing Begins
Supporters of health reform said it would never happen. Maybe they got caught up in their own rhetoric. Maybe they just didn’t want to believe it was possible. But rationing in America has started. By December, the Food and Drug Administration is expected to revoke approval of the drug Avastin ...
Federal Pre-Emption Has a Place, but Maybe Not This One
Jay Lefkowitz and Michael Shumsky (“Obama Embraces the ‘Pre-Emption’ Doctrine,” op-ed, Sept. 14) make some valid arguments applicable to legal trade-offs between states’ product-liability laws and the Food and Drug Administration’s labeling regulations. However, they are off-base in describing the FDA as “cash-strapped.” The FDA’s spending on the regulation of ...
GOP Pledge on Health Care: “Repeal” is Great; “Replace” Needs Work
Read my entire response at National Review Online .
